Presented by Karolina Jackowska at the ESCMID Global Conference in Barcelona, 2024 Download the High Resolution PDF below:

Download the full paper below: Abstract Bacterial healthcare-associated infections (HAIs) are a substantial source of global morbidity and mortality. The estimated cost associated with HAIs ranges from $35 to $45 billion in the USA alone. The costs and accessibility of whole genome sequencing (WGS) of bacteria and the lack of sufficiently accurate, high-resolution, scalable and accessible analysis for strain identification are being addressed. Thus, it is timely to determine

Presented by Georgina Russell at ASM Microbe in Houston, Texas 2023 Download high resolution PDF below: Supplementary Information

Presented by Arthur Poivet at ASM Microbe in Houston, Texas 2023 Download high-resolution pdf below: Supplementary Information

Presented by Karolina Jackowska at ASM Microbe in Houston, Texas 2023 Download the high-resolution pdf below: Supplementary Information

Presented by Rebecca Ji Bengtsson at ASM Microbe in Houston, Texas 2023 Download the high-resolution pdf below: Supplementary Information

Presented by Ramiro Morales-Hojas at ASM Microbe in Houston, Texas 2023 Download high-resolution pdf below: Supplementary Information

Presented by James Littlefair at ASM Microbe in Houston, Texas 2023 Download high-resolution pdf below: Supplementary Information

Presented by John Fox at ASM Microbe in Houston, Texas 2024 Bacterial HAIs are a substantial source of global morbidity and mortality, resulting in increased length of hospital stay and high healthcare costs. At Genpax, we're often asked what the benefit of adopting a WGS led intervention strategy could have on hospitals systems, so we developed at thorough model to work it out. Our findings will be presented at the forthcoming ASM Microbe 23 meeting in Houston in June. If y

Presented by James Littlefair at ECCMID in Copenhagen, 2023 Download high-resolution pdf below: At ECCMID 2023 in Copenhagen, we displayed some of the findings regarding our near-zero error capabilities generated from our platform which will be launched commercially this summer. Calling Zero: A new foundation for diagnostic bacterial genomics James C. Littlefair, Benedict J. Uttley, Dan G. Frampton, Gareth M. Linsmith, John F. Peden, & Nigel J. Saunders Reference ECCMID

Download high-resolution pdf below: A Novel Multi-Scale Outbreak Detection and Strain Identification Capability for Genome Sequence-Based Infection Control: An MRSA Example. J. C. Littlefair, B. Uttley, D. Frampton, J. F. Peden, N. J. Saunders The exclusion (as well as inclusion) of strains is vital for outbreak investigation and infection prevention and control of healthcare-associated infection, for both health resource management and patient-care. Current genome-sequence b